NGAL and cystatin C: Two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: One year follow up

Hormones

Volumn 14, Issue 2, 2015, Pages 232-240

  Papadopoulou Marketou, Nektraria ^a,b   Skevaki, Chrysanthi ^c   Kosteria, Ioanna ^a   Peppa, Melpomeni ^d   Chrousos, George P ^a,e   Papassotiriou, Ioannis ^c   Kanaka Gantenbein, Christina ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b LINKÖPING UNIVERSITY   (Sweden)

^c Department of Clinical Biochemistry Aghia Sophia Children s Hospital   (Saudi Arabia)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^e KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Cystatin C; Diabetes induced nephropathy; NGAL; Type 1 diabetes; Youth

Indexed keywords

CREATININE; CYSTATIN C; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ADOLESCENT; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CHILD; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NEPHELOMETRY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROTEIN DETERMINATION; PROTEIN FUNCTION; SCHOOL CHILD; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; BLOOD; DIABETIC NEPHROPATHIES; KIDNEY; PATHOPHYSIOLOGY; PROGNOSIS;

ACUTE-PHASE PROTEINS; ADOLESCENT; BIOMARKERS; CHILD; CYSTATIN C; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; LIPOCALINS; MALE; PROGNOSIS; PROTO-ONCOGENE PROTEINS;

EID: 84932645468     PISSN: 11093099     EISSN: 25208721     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Nichols GA, Vupputuri S, Lau H, 2011 Medical care costs associated with progression of diabetic nephropathy. Diabetes Care 34: 2374-2378.
2. Perkins BA, Krolewski AS, 2005 Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress. Curr Diab Rep 5: 455-463.
3. R aile K, Galler A, Hofer S, et al, 2007 Diabetic nephropathy in 27, 805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 30: 2523-2528.
4. Mogensen CE, 1997 How to protect the kidney in diabetic patients: with special reference to IDDM. Diabetes 46: Suppl 2: 104-111.
5. Schultz CJ, Konopelska-Bahu T, Dalton RN, et al, 1999 Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care 22: 495-502.
6. Perkins BA, Ficociello LH, Silva KH, et al, 2003 Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348: 2285-2293.
7. A ccess O, 2009 Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). BMC Pediatr 9: 79.
8. L acquaniti A, Donato V, Pintaudi B, et al, 2013 "Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL. Acta Diabetol 50: 935-942.
9. Hovind P, Rossing P, Tarnow L, et al, 2009 Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study. Diabetes 58: 1668-1671.
10. Perkins BA, Ficociello LH, Roshan B, et al, 2010 In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int 77: 57-64.
11. O rchard TJ, Forrest KY, Kuller LH, Becker DJ, 2001 Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 24: 1053-1059.
12. Caramori ML, Kim Y, Huang C, et al, 2002 Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 51: 506-513.
13. Schultz CJ, Amin R, Dunger DB, 2002 Markers of microvascular complications in insulin dependent diabetes. Arch Dis Child 87: 10-12.
14. O rchard TJ, 1994 From diagnosis and classification to complications and therapy. DCCT. Part II? Diabetes Control and Complications Trial. Diabetes Care 17: 326-338.
15. E llis EN, Warady BA, Wood EG, et al, 1997 Renal structural-functional relationships in early diabetes mellitus. Pediatr Nephrol 11: 584-591.
16. D rummond KN, Kramer MS, Suissa S, et al, 2003 Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes 52: 1818-1824.
17. Steinke JM, Sinaiko AR, Kramer MS, et al, 2005 The early natural history of nephropathy in type 1 diabetes. Diabetes 54: 2164-2171.
18. T orbjörnsdotter TB, Perrin NESS, Jaremko GA, Berg UB, 2005 Widening of foot processes in normoalbuminuric adolescents with type 1 diabetes. Pediatr Nephrol 20: 750-758.
19. Nauta FL, Boertien WE, Bakker SJL, et al, 2011 Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care 34: 975-981.
20. Chae H-W, Shin J-I, Kwon A-R, et al, 2012 Spot urine albumin to creatinine ratio and serum cystatin C are effective for detection of diabetic nephropathy in childhood diabetic patients. J Korean Med Sci 27: 784-787.
21. T hrailkill KM, Moreau CS, Cockrell GE, et al, 2010 Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus. Endocrine 37: 336-343.
22. Schmidt-Ott KM, Mori K, Li JY, et al, 2007 Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 18: 407-413.
23. D evarajan P, 2010 Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med 4: 265-280.
24. Bagshaw SM, Bennett M, Haase M, et al., 2010 Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med 36: 452-461.
25. Haase-Fielitz A, Haase M, Devarajan P, 2014 Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status. Ann Clin Biochem 51: 335-351.
26. McKittrick IB, Bogaert Y, Nadeau K, et al, 2011 Urinary matrix metalloproteinase activities: biomarkers for plaque angiogenesis and nephropathy in diabetes. Am J Physiol Renal Physiol 301: 1326-1333.
27. Hawkins R, 2011 New biomarkers of acute kidney injury and the cardio-renal syndrome. Korean J Lab Med 31: 72-80.
28. D harnidharka VR, Kwon C, Stevens G, 2002 Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40: 221-226.
29. Finney H, Newman DJ, Thakkar H, et al, 2000 Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child 82: 71-75.
30. Grubb A, Björk J, Nyman U, et al, 2011 Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation. Scand J Clin Lab Invest 71: 145-149.
31. Maahs DM, Ogden LG, Kretowski A, et al, 2007 Serum Cystatin C Predicts Progression of Subclinical Coronary Atherosclerosis in Individuals With Type 1 Diabetes. Diabetes 56: 2774-2779.
32. Codoñer-Franch P, Ballester-Asensio E, Martínez-Pons L, et al, 2011 Cystatin C, cardiometabolic risk, and body composition in severely obese children. Pediatr Nephrol 26: 301-307.
33. Brown SC, O'Reilly PH, 1991 Iohexol clearance for the determination of glomerular filtration rate in clinical practice: evidence for a new gold standard. J Urol 146: 675-679.
34. Schwartz GJ, Schneider MF, Maier PS, et al, 2012 Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int 82: 445-453.
35. Schwartz GJ, Work DF, 2009 Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4: 1832-1843.
36. Grubb A, 2010 Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: Simultaneous use of cystatin C-and creatinine-based GFR-prediction equations, clinical data and an internal quality check. Scand J Clin Lab Invest 70: 65-70.
37. Perkins BA, Krolewski AS, 2009 Early nephropathy in type 1 diabetes: the importance of early renal function decline. Curr Opin Nephrol Hypertens 18: 233-240.
38. Marcun N, 2013 Microalbuminuria in pediatric patients with hypertension. Health 5: 40-46.
39. Ix JH, Shlipak MG, Chertow GM, Whooley MA, 2007 Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 115: 173-179.
40. U hlig K, Eckardt K-U, 2012 A decade after the KDOQI CKD guidelines: impact on CKD guidelines. Am J Kidney Dis 60: 705-706.